Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Greenberg

Showing results (611-620 of 696) with videos related to

Pageof 70
Sort By:
European Journal of Heart Failure|September 17, 2022
Characteristics and clinical outcomes of patients with acute heart failure with a supranormal left ventricular ejection fractionBart J van Essen, Jasper Tromp, Jozine M Ter Maaten, et al.
JACC. Heart Failure|October 10, 2021
Association of Early Blood Pressure Decrease and Renal Function With Prognosis in Acute Heart FailureYuya Matsue, Iziah E Sama, Douwe Postmus, et al.
JACC. Heart Failure|April 4, 2016
Use of High-Sensitivity Troponin T to Identify Patients With Acute Heart Failure at Lower Risk for Adverse Outcomes: An Exploratory Analysis From the RELAX-AHF TrialPeter S Pang, John R Teerlink, Adriaan A Voors, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|February 3, 2017
Serelaxin in acute heart failure patients with and without atrial fibrillation: a secondary analysis of the RELAX-AHF trialGerasimos Filippatos, Dimitrios Farmakis, Marco Metra, et al.
Anti-Cancer Drugs|August 1, 1997
An update of a phase II study of paclitaxel in advanced or recurrent squamous cell cancer of the cervixA P Kudelka, R Winn, C L Edwards, et al.
JAMA|December 11, 1996
Lymphatic mapping and sentinel node biopsy in the patient with breast cancerJ J Albertini, G H Lyman, C Cox, et al.
American Heart Journal|May 26, 2009
Influence of coronary angiography on the utilization of therapies in patients with acute heart failure syndromes: findings from Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF)James D Flaherty, Joseph S Rossi, Gregg C Fonarow, et al.
European Journal of Heart Failure|November 14, 2008
Influence of coronary artery disease and coronary revascularization status on outcomes in patients with acute heart failure syndromes: a report from OPTIMIZE-HF (Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure)Joseph S Rossi, James D Flaherty, Gregg C Fonarow, et al.
American Heart Journal|April 30, 2017
Day vs night: Does time of presentation matter in acute heart failure? A secondary analysis from the RELAX-AHF trialPeter S Pang, John R Teerlink, Leandro Boer-Martins, et al.
European Journal of Heart Failure|April 29, 2017
Serelaxin in addition to standard therapy in acute heart failure: rationale and design of the RELAX-AHF-2 studyJohn R Teerlink, Adriaan A Voors, Piotr Ponikowski, et al.
Pageof 70

Showing results (611-620 of 696) with videos related to

Sort By:
Pageof 70
European Journal of Heart Failure|September 17, 2022
Characteristics and clinical outcomes of patients with acute heart failure with a supranormal left ventricular ejection fractionBart J van Essen, Jasper Tromp, Jozine M Ter Maaten, et al.
JACC. Heart Failure|October 10, 2021
Association of Early Blood Pressure Decrease and Renal Function With Prognosis in Acute Heart FailureYuya Matsue, Iziah E Sama, Douwe Postmus, et al.
JACC. Heart Failure|April 4, 2016
Use of High-Sensitivity Troponin T to Identify Patients With Acute Heart Failure at Lower Risk for Adverse Outcomes: An Exploratory Analysis From the RELAX-AHF TrialPeter S Pang, John R Teerlink, Adriaan A Voors, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|February 3, 2017
Serelaxin in acute heart failure patients with and without atrial fibrillation: a secondary analysis of the RELAX-AHF trialGerasimos Filippatos, Dimitrios Farmakis, Marco Metra, et al.
Anti-Cancer Drugs|August 1, 1997
An update of a phase II study of paclitaxel in advanced or recurrent squamous cell cancer of the cervixA P Kudelka, R Winn, C L Edwards, et al.
JAMA|December 11, 1996
Lymphatic mapping and sentinel node biopsy in the patient with breast cancerJ J Albertini, G H Lyman, C Cox, et al.
American Heart Journal|May 26, 2009
Influence of coronary angiography on the utilization of therapies in patients with acute heart failure syndromes: findings from Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF)James D Flaherty, Joseph S Rossi, Gregg C Fonarow, et al.
European Journal of Heart Failure|November 14, 2008
Influence of coronary artery disease and coronary revascularization status on outcomes in patients with acute heart failure syndromes: a report from OPTIMIZE-HF (Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure)Joseph S Rossi, James D Flaherty, Gregg C Fonarow, et al.
American Heart Journal|April 30, 2017
Day vs night: Does time of presentation matter in acute heart failure? A secondary analysis from the RELAX-AHF trialPeter S Pang, John R Teerlink, Leandro Boer-Martins, et al.
European Journal of Heart Failure|April 29, 2017
Serelaxin in addition to standard therapy in acute heart failure: rationale and design of the RELAX-AHF-2 studyJohn R Teerlink, Adriaan A Voors, Piotr Ponikowski, et al.
Pageof 70